The UC Davis Department of Ophthalmology received a five-year, $3.6 million grant from the National Eye Institute to explore a new way to treat vision loss using gene therapy.

A new cosmetic surgery trend has gained momentum as an option for those interested in permanently changing their eye color, but some experts are cautioning against the procedure.

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

Cow Makeup Meets Otaku Lenses – Eye Color ChallengeMore for You Listen: Fans boo President Trump at the FIFA Club World Cup Final Superman fans left conflicted about controversial plot twist in ...

Gene Hackmand and wife Betsy Arakawa left behind a staggering amount of credit card debt, leaving their estates in turmoil.

Company News Published 07/09/2025, 07:19 AM 0 Krystal Biotech begins phase 1/2 trial of eye drop gene therapy for NK KRYS 2.02% ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a ...

Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.

Discover the rarest eye colour in the world—red or violet—found in less than 1 in 50,000 people due to ocular albinism.

Sarepta's gene therapy pipeline faces renewed scrutiny after a third patient death and FDA plans for a black box warning on Elevidys.